Date | Title | Description | Source |
13.03.2024 | Global gRNA Research Analysis Report 2024: Precision in Gene... | - | globenewsw... |
26.09.2023 | Revvity expands access to base editing technology with aim t... | Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology
Acc... | cambridgen... |
15.06.2022 | YCharOS adds Developmental Studies Hybridoma Bank (DSHB) to ... | YCharOS continues to expand Industry Advisory Committee and releases new open data
Adding an academi... | einpresswi... |
21.03.2022 | YCharOS adds ABclonal Technology to Industry Advisory Commit... | YCharOS continues to expand Industry Advisory Committee and releases new open data TORONTO, CANADA, ... | einpresswi... |
03.02.2022 | PerkinElmer : to Showcase Expanded Life Science / Cell &... | PDF Version
End-to-end solutions designed to help scientists streamline and improve
drug discovery R... | marketscre... |
07.10.2021 | PerkinElmer’s Horizon Discovery CHOSOURCE platform expands | PerkinElmer’s Horizon Discovery CHOSOURCE platform expands
07-10-2021
Existing CHO platform, featuri... | cambridgen... |
07.10.2021 | PerkinElmer’s Horizon Discovery CHOSOURCE platform expands | Existing CHO platform, featuring low cost and no royalty or licence tie-ins, expands with new cell l... | cambridgen... |
11.05.2021 | Appia Bio Comes Out of Stealth Aiming to Offer Faster, Safer... | Cell therapy has taken the oncology world by storm.
For cancer patients who have tried every other t... | dot.la/all... |
30.03.2021 | Horizon Discovery extends gene modulation portfolio | CRISPRi innovations provide expanded experimental options and flexibility for researchers, facilitat... | cambridgen... |
30.03.2021 | Horizon Discovery extends gene modulation portfolio | Horizon Discovery extends gene modulation portfolio
30-03-2021
CRISPRi innovations provide expanded ... | cambridgen... |
02.11.2020 | PerkinElmer to acquire cell engineering company Horizon Disc... | PerkinElmer to acquire cell engineering company Horizon Discovery for £296m ($383m)
02-11-2020
Perki... | cambridgen... |
30.04.2020 | Horizon Discovery extends coverage of OncoSpan reference sta... | Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy
30-04-2... | cambridgen... |
30.04.2020 | Horizon Discovery extends coverage of OncoSpan reference sta... | Horizon Discovery Group plc (LSE: HZD), a global leader in the application of gene editing and gene ... | cambridgen... |
14.04.2020 | Horizon Discovery offers CHOSOURCE™ platform for COVID-19-re... | Horizon Discovery offers CHOSOURCE™ platform for COVID-19-related therapeutics and diagnostics
14-04... | cambridgen... |
06.04.2020 | Horizon Discovery expands cell-based CRISPR screening servic... | Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation ... | cambridgen... |
06.04.2020 | Horizon Discovery expands cell-based CRISPR screening servic... | Horizon Discovery expands cell-based CRISPR screening services
06-04-2020
Horizon Discovery Group pl... | cambridgen... |
30.01.2020 | Mammoth Biosciences aims to be Illumina for the gene editing... | In 1998, the startup company Illumina launched a revolution in the life sciences industry by develop... | techcrunch... |
30.01.2020 | Mammoth Biosciences raises $45M to expand into therapeutics | The company, which uses CRISPR technology to diagnose diseases, will being treating disease as well
... | vator.tv/n... |
28.10.2019 | Horizon Discovery reaches integration milestone and launches... | Horizon Discovery reaches integration milestone and launches new website
28-10-2019
Horizon Discover... | cambridgen... |
28.10.2019 | Horizon Discovery reaches integration milestone and launches... | Horizon Discovery Group plc (LSE: HZD), a global leader in the application of gene editing and gene ... | cambridgen... |
30.09.2019 | Horizon Discovery signs licence agreement with Glenmark Phar... | Horizon Discovery signs licence agreement with Glenmark Pharmaceuticals for GS knockout CHO cell lin... | cambridgen... |
24.09.2018 | Horizon Discovery Myeloid DNA Reference Standard supports ge... | Horizon Discovery Myeloid DNA Reference Standard supports genetic testing of leukemia
24-09-2018
Hor... | cambridgen... |
14.09.2018 | Horizon Discovery Edit-R crRNA libraries adopted by AstraZen... | Horizon Discovery Edit-R crRNA libraries adopted by AstraZeneca
14-09-2018
Horizon Discovery Group p... | cambridgen... |
12.04.2018 | Horizon and Pirbright Institute support research into improv... | Horizon and Pirbright Institute support research into improvement of vaccine yields
12-04-2018
Horiz... | cambridgen... |
27.09.2017 | Horizon Discovery Group delivers consistent strong growth | Horizon Discovery Group delivers consistent strong growth
27-09-2017
Horizon Discovery Group plc, a ... | cambridgen... |
01.08.2017 | Horizon Discovery releases CHO genome sequence to drive inno... | Horizon Discovery releases CHO genome sequence to drive innovation in bioproduction
01-08-2017
Horiz... | cambridgen... |
19.07.2017 | Horizon Discovery Group plc acquires GE Healthcare Dharmacon... | Horizon Discovery Group plc acquires GE Healthcare Dharmacon, Inc. for $85 million
19-07-2017
Horizo... | cambridgen... |
17.07.2017 | Sphere Fluidics and partners win InnovateUK grant to develop... | Sphere Fluidics and partners win InnovateUK grant to develop the world’s first desktop genome
17-07-... | cambridgen... |
08.03.2017 | Horizon Discovery partners with Amplycell SA for bioproducti... | Horizon Discovery partners with Amplycell SA for bioproduction cell line optimisation
08-03-2017
Hor... | cambridgen... |
14.02.2017 | Horizon Discovery signs a Master Service Agreement with a to... | Horizon Discovery signs a Master Service Agreement with a top three pharmaceutical company
14-02-201... | cambridgen... |
19.10.2016 | Horizon Discovery signs licensing agreement for biomanufactu... | Horizon Discovery signs licensing agreement for biomanufacturing cell lines
19-10-2016
Horizon Disco... | cambridgen... |
06.09.2016 | Horizon Discovery and Fulcrum Therapeutics collaborate for n... | Horizon Discovery and Fulcrum Therapeutics collaborate for novel target discovery
06-09-2016
Horizon... | cambridgen... |
01.09.2016 | Horizon Discovery Group and Ventana Medical Systems sign agr... | Horizon Discovery Group and Ventana Medical Systems sign agreement for reference standards
01-09-201... | cambridgen... |
02.03.2016 | Horizon Discovery Group forms joint venture with Centauri Th... | Horizon Discovery Group forms joint venture with Centauri Therapeutics Limited
02-03-2016
Horizon Di... | cambridgen... |
22.07.2015 | Horizon Discovery Group plc publishes trading update | Horizon Discovery Group plc publishes trading update
22-07-2015
Horizon Discovery Group plc, the int... | cambridgen... |
17.06.2015 | Preparing for AIM listing? Maximise your company’s value | Preparing for AIM listing? Maximise your company’s value
17-06-2015
Marketing is often considered an... | cambridgen... |
17.06.2015 | Preparing for AIM listing? Maximise your company’s value | Marketing is often considered an afterthought for science and technology companies preparing for an ... | cambridgen... |
14.04.2015 | Horizon reports strong maiden full year results since listin... | Horizon reports strong maiden full year results since listing on AIM
14-04-2015
Horizon Discovery Gr... | cambridgen... |
23.03.2015 | Horizon Discovery Group plc and ArcherDX sign OEM agreement | Horizon Discovery Group plc and ArcherDX sign OEM agreement
23-03-2015
Horizon’s Reference Materials... | cambridgen... |
11.03.2015 | Horizon Discovery Group plc supports Cancer Research UK’s St... | Horizon Discovery Group plc supports Cancer Research UK’s Stratified Medicine Programme
11-03-2015
H... | cambridgen... |
18.02.2015 | Horizon Discovery Group part of consortium awarded £1.67m In... | Horizon Discovery Group part of consortium awarded £1.67m Innovate UK funding
18-02-2015
Horizon Dis... | cambridgen... |
02.02.2015 | Horizon selected as core facility by Tri-Institutional Thera... | Horizon selected as core facility by Tri-Institutional Therapeutics Discovery Institute
02-02-2015
H... | cambridgen... |
29.01.2015 | Horizon Discovery CEO Darrin Disley wins 'Entrepreneur of th... | Horizon Discovery CEO Darrin Disley wins 'Entrepreneur of the Year' award
29-01-2015
Horizon Discove... | cambridgen... |
19.01.2015 | Horizon Discovery Group plc trading update shows continuing ... | Horizon Discovery Group plc trading update shows continuing growth
19-01-2015
Revenues for Horizon D... | cambridgen... |
08.01.2015 | Horizon Discovery Group plc acquires Haplogen Genomics GmbH | Horizon Discovery Group plc acquires Haplogen Genomics GmbH
08-01-2015
Strategic acquisition of high... | cambridgen... |
08.12.2014 | Horizon launches gene-engineered bioproduction cell line wit... | Horizon's precisely engineered cell line will facilitate a new revenue stream and enable faster, mor... | cambridgen... |
08.12.2014 | Horizon launches gene-engineered bioproduction cell line wit... | Horizon launches gene-engineered bioproduction cell line with flexible licensing model
08-12-2014
Ho... | cambridgen... |
04.12.2014 | Horizon Discovery CEO Darrin Disley wins Executive of the Ye... | Horizon Discovery CEO Darrin Disley wins Executive of the Year award at SCRIP Awards 2014
04-12-2014... | cambridgen... |
24.11.2014 | Horizon Discovery Group plc and Adarza BioSystems enter supp... | Horizon Discovery Group plc and Adarza BioSystems enter supply & licensing agreement
24-11-2014
... | cambridgen... |
17.11.2014 | Horizon Discovery Group signs agreement with top pharma comp... | Horizon Discovery Group signs agreement with top pharma company for approximately $750,000
17-11-201... | cambridgen... |
03.11.2014 | Horizon Discovery Group plc appoints Dr David Smoller as an ... | Horizon Discovery Group plc appoints Dr David Smoller as an Executive Director
03-11-2014
Horizon Di... | cambridgen... |
23.10.2014 | Horizon launches collection of Patient-Derived Xenograft mod... | Horizon launches collection of Patient-Derived Xenograft models of breast cancer
23-10-2014
Horizon ... | cambridgen... |
23.10.2014 | Horizon launches collection of Patient-Derived Xenograft mod... | Horizon Discovery Group plc, a leading provider of products, services and technologies in the field ... | cambridgen... |
29.09.2014 | Horizon Discovery Group plc acquires Sage Labs Inc. for $48M... | Horizon Discovery Group plc acquires Sage Labs Inc. for $48M (£29M)
29-09-2014
Horizon Discovery Gro... | cambridgen... |
23.09.2014 | Horizon Discovery reports a strong first half, positioning f... | Horizon Discovery reports a strong first half, positioning for continued growth
23-09-2014
Horizon D... | cambridgen... |
31.08.2014 | Horizon Discovery Group plc Acquires Sage Labs Inc. for $48M... | Acquisition makes Horizon the world’s leading gene-editing and translational genomics company
Cambr... | thpartners... |
14.08.2014 | KISS team cycles from London to Cambridge, raising over £900... | KISS team cycles from London to Cambridge, raising over £900 for Breakthrough Breast Cancer
14-08-20... | cambridgen... |
14.08.2014 | KISS team cycles from London to Cambridge, raising over £900... | On Sunday 27th July, a 12-strong team from KISS Communications, a leading Cambridge creative agency,... | cambridgen... |
05.08.2014 | Horizon Discovery adds three eminent CRISPR experts to its S... | Horizon Discovery adds three eminent CRISPR experts to its Scientific Advisory Board
05-08-2014
Hori... | cambridgen... |
23.07.2014 | Horizon Discovery reports strong performance | Horizon Discovery reports strong performance
23-07-2014
Horizon Discovery Group plc, the internation... | cambridgen... |
19.06.2014 | KISS helps prepare pupils for the world of work | KISS helps prepare pupils for the world of work
19-06-2014
Cambridge Area 14-19 Partnership (CAP) ha... | cambridgen... |
16.06.2014 | Horizon Discovery and LGC awarded grant for next generation ... | Horizon Discovery and LGC awarded grant for next generation cancer diagnostics
16-06-2014
Improving ... | cambridgen... |
12.06.2014 | Horizon Discovery licenses CRISPR gene editing technology fr... | Horizon Discovery licenses CRISPR gene editing technology from the Broad Institute
12-06-2014
Horizo... | cambridgen... |
11.06.2014 | KISS PR partners with Cambridge Roar | KISS PR partners with Cambridge Roar
11-06-2014
KISS PR has been appointed by The Cambridge Roar to ... | cambridgen... |
09.06.2014 | Horizon Discovery strengthens Board with appointment of Non-... | Horizon Discovery strengthens Board with appointment of Non-Executive Directors
09-06-2014
Horizon D... | cambridgen... |
02.06.2014 | Horizon completes acquisition of CombinatoRx service busines... | Horizon completes acquisition of CombinatoRx service business and assets from Zalicus Inc.
02-06-201... | cambridgen... |
15.05.2014 | Horizon Discovery Group plc to acquire CombinatoRx service b... | Horizon Discovery Group plc to acquire CombinatoRx service business from Zalicus Inc.
15-05-2014
In ... | cambridgen... |
07.04.2014 | Horizon Discovery launches new gene editing tools and servic... | Horizon Discovery™ Group plc (LSE: HZD), the life science company supplying research tools to organi... | cambridgen... |
07.04.2014 | Horizon Discovery launches new gene editing tools and servic... | Horizon Discovery launches new gene editing tools and services
07-04-2014
Horizon Discovery™ Group p... | cambridgen... |
24.03.2014 | Horizon Discovery Group plc raises £68.6 million | Horizon Discovery Group plc raises £68.6 million
24-03-2014
Horizon Discovery Group plc, the revenue... | cambridgen... |
18.02.2014 | Horizon Discovery signs supply and distribution agreement wi... | Horizon Discovery signs supply and distribution agreement with Sirion Biotech GmbH
18-02-2014
Horizo... | cambridgen... |
12.02.2014 | Horizon Discovery signs distribution agreement with Haplogen | Horizon Discovery signs distribution agreement with Haplogen
12-02-2014
Horizon will market and dist... | cambridgen... |
10.02.2014 | Horizon Discovery launches kits and reagents for gene-editin... | Horizon Discovery launches kits and reagents for gene-editing
10-02-2014
Horizon Discovery™, a leadi... | cambridgen... |
10.02.2014 | Horizon Discovery launches kits and reagents for gene-editin... | Horizon Discovery™, a leading provider of research tools to support translational genomics and the d... | cambridgen... |
07.01.2014 | Horizon Discovery announces new oncology research and collab... | Horizon Discovery and AstraZeneca have entered into a research, collaboration and licence agreement ... | cambridgen... |
07.01.2014 | Horizon Discovery announces new oncology research and collab... | Horizon Discovery announces new oncology research and collaboration with AstraZeneca
07-01-2014
Hori... | cambridgen... |
22.11.2013 | Horizon Discovery and AstraZeneca win “Licensing Deal of the... | CAMBRIDGE–(BUSINESS WIRE)–November 22, 2013–
Horizon Discovery (Horizon) has won “Licensing Deal of ... | venturebea... |
23.10.2013 | David Evans steps down as Chairman of the Board for Horizon ... | David Evans steps down as Chairman of the Board for Horizon Discovery
23-10-2013
Horizon Discovery, ... | cambridgen... |
15.10.2013 | Horizon Discovery receives share of €5.75M ($7.8M) EU FP7 gr... | Horizon Discovery receives share of €5.75M ($7.8M) EU FP7 grant
15-10-2013
Horizon Discovery, a lead... | cambridgen... |
15.10.2013 | Horizon Discovery receives share of €5.75M ($7.8M) EU FP7 gr... | Horizon Discovery, a leading provider of research tools to support the development of personalised m... | cambridgen... |
08.10.2013 | Horizon Discovery and Blueprint Medicines enter oncology res... | Horizon Discovery and Blueprint Medicines enter oncology research service agreement
08-10-2013
Horiz... | cambridgen... |
16.09.2013 | Horizon Discovery licenses CRISPR gene editing technology fr... | Horizon Discovery licenses CRISPR gene editing technology from Harvard University
16-09-2013
Horizon... | cambridgen... |
03.09.2013 | Inspiring the next wave of bio innovation | Inspiring the next wave of bio innovation
03-09-2013
The forthcoming 'Beating the odds in biobusines... | cambridgen... |
03.06.2013 | Horizon Discovery announces £6.9 million Series C continuati... | Horizon Discovery, a leading provider of research tools to support the development of personalized m... | cambridgen... |
03.06.2013 | Horizon Discovery announces £6.9 million Series C continuati... | Horizon Discovery announces £6.9 million Series C continuation fundraising
03-06-2013
Horizon Discov... | cambridgen... |
22.04.2013 | Horizon Discovery announces >$75M oncology drug discovery... | Horizon Discovery and AstraZeneca have entered into an exclusive collaboration and licence agreement... | cambridgen... |
22.04.2013 | Horizon Discovery announces >$75M oncology drug discovery... | Horizon Discovery announces >$75M oncology drug discovery collaboration with AstraZeneca
22-04-20... | cambridgen... |
03.04.2013 | Crown Bioscience Inc. and Horizon Discovery announce exclusi... | Crown Bioscience Inc. and Horizon Discovery announce exclusive two year agreement...
03-04-2013
Crow... | cambridgen... |
14.01.2013 | Horizon Discovery and Boehringer Ingelheim enter oncology re... | Horizon Discovery and Boehringer Ingelheim enter oncology research service collaboration
14-01-2013
... | cambridgen... |
08.01.2013 | Zyme and KISS collaborate to redevelop website for Horizon D... | Zyme and KISS collaborate to redevelop website for Horizon Discovery
08-01-2013
Life science PR and ... | cambridgen... |
16.11.2012 | Horizon Discovery launches new website | Horizon Discovery launches new website
16-11-2012
Horizon Discovery Ltd, a leading provider of resea... | cambridgen... |
16.11.2012 | Horizon Discovery launches new website | Horizon Discovery Ltd, a leading provider of research tools to support the development of personaliz... | cambridgen... |
13.11.2012 | Horizon Discovery and Promega launch suite of X-MAN reporter... | Horizon Discovery and Promega launch suite of X-MAN reporter kits
13-11-2012
Horizon Discovery Ltd.,... | cambridgen... |
06.11.2012 | Crown Bioscience, Inc. and Horizon Discovery at EORTC-NCI-AA... | Crown Bioscience, Inc. and Horizon Discovery at EORTC-NCI-AACR Symposium
06-11-2012
Santa Clara, CA ... | cambridgen... |
06.08.2012 | Horizon Discovery and Domainex Ltd collaborate to support le... | Horizon Discovery and Domainex Ltd collaborate to support lead optimization oncology program
06-08-2... | cambridgen... |
31.07.2012 | Horizon Discovery appoints Richard Vellacott as Chief Financ... | Horizon Discovery appoints Richard Vellacott as Chief Financial Officer
31-07-2012
Horizon Discovery... | cambridgen... |
25.07.2012 | Horizon Discovery collaborates with NIH Center for Regenerat... | Horizon Discovery collaborates with NIH Center for Regenerative Medicine
25-07-2012
Horizon Discover... | cambridgen... |
01.05.2012 | Horizon Discovery and H3 Biomedicine collaborate to validate... | Horizon Discovery and H3 Biomedicine collaborate to validate novel cancer targets
01-05-2012
H3 Biom... | cambridgen... |
23.04.2012 | Horizon Discovery receives Queen’s Award for Enterprise in I... | Horizon Discovery receives the Queen’s Award for Enterprise in International Trade - the UK’s most p... | cambridgen... |
23.04.2012 | Horizon Discovery receives Queen’s Award for Enterprise in I... | Horizon Discovery receives Queen’s Award for Enterprise in International Trade
23-04-2012
Horizon Di... | cambridgen... |